Mind Medicine Inc.: Diferență între versiuni
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
||
| Linia 2: | Linia 2: | ||
==Descriere companie== | ==Descriere companie== | ||
Mind Medicine (https://mindmed.co/) Inc. is a Canada-based clinical-stage psychedelic medicine biotechnology company. The Company focuses on discovering, developing and deploying psychedelic-inspired medicines and therapies to address addiction and mental illness. The Company's commercial drug development programs includes lysergic acid diethylamide (LSD) experiential therapy, 18-methoxycoronaridine (18-MC) opioid withdrawal, LSD microdosing, methylenedioxymethamphetamine (MDMA), and dimethyltryptamine (DMT). The Company's subsidiaries include Mind Medicine, Inc., HealthMode, Inc., MindMed Pty Ltd. and MindMed GmbH. | [[MIND|Mind]] Medicine (https://mindmed.co/) Inc. is a Canada-based clinical-stage psychedelic medicine biotechnology company. The Company focuses on discovering, developing and deploying psychedelic-inspired medicines and therapies to address addiction and mental illness. The Company's commercial drug development programs includes lysergic acid diethylamide (LSD) experiential therapy, 18-methoxycoronaridine (18-MC) opioid withdrawal, LSD microdosing, methylenedioxymethamphetamine (MDMA), and dimethyltryptamine (DMT). The Company's subsidiaries include Mind Medicine, Inc., HealthMode, Inc., MindMed Pty Ltd. and MindMed GmbH. | ||
==Grafic actiuni companie== | ==Grafic actiuni companie== | ||
Versiunea curentă din 27 noiembrie 2024 05:55
Pagina dedicata companiei Mind Medicine Inc. listata cu simbolul US.MNMD
Descriere companie[edit | ]
Mind Medicine (https://mindmed.co/) Inc. is a Canada-based clinical-stage psychedelic medicine biotechnology company. The Company focuses on discovering, developing and deploying psychedelic-inspired medicines and therapies to address addiction and mental illness. The Company's commercial drug development programs includes lysergic acid diethylamide (LSD) experiential therapy, 18-methoxycoronaridine (18-MC) opioid withdrawal, LSD microdosing, methylenedioxymethamphetamine (MDMA), and dimethyltryptamine (DMT). The Company's subsidiaries include Mind Medicine, Inc., HealthMode, Inc., MindMed Pty Ltd. and MindMed GmbH.
Grafic actiuni companie[edit | ]